Related Experiment Video
Updated: Nov 11, 2025

A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Current and future treatment options for adrenal insufficiency
Muhammad Fahad Arshad1, Miguel Debono
1Department of Endocrinology and Diabetes, Sheffield Teaching Hospitals, Royal Hallamshire Hospital, Sheffield, UK.
Novel glucocorticoid therapies improve outcomes for patients with adrenal insufficiency (AI) by mimicking natural cortisol rhythms. These advanced treatments offer better quality of life and metabolic control compared to traditional methods.
Area of Science:
- Endocrinology
- Pharmacology
Background:
- Patients with adrenal insufficiency (AI) experience high morbidity and mortality, partly due to conventional glucocorticoid therapy failing to replicate physiological cortisol rhythms.
- Current treatments often do not adequately manage the complex hormonal needs of AI patients.
Purpose of the Study:
- To review novel strategies for glucocorticoid replacement therapy in AI.
- To assess the benefits of new formulations designed to mimic the natural cortisol rhythm.
Main Methods:
- Review of recent studies on novel glucocorticoid replacement therapies including hydrocortisone infusion pumps and modified-release oral hydrocortisone.
- Analysis of findings from studies like DREAM, comparing new therapies to conventional glucocorticoid dosing.
Main Results:
- Modified-release hydrocortisone (Plenadre) improved quality of life, reduced weight, immunosuppression, and infections compared to multiple daily dosing.
- Early morning cortisol-releasing formulations (Chronocort) enhanced androgen concentrations in congenital adrenal hyperplasia (CAH).
- Physiological hydrocortisone infusion pumps improved cortisol profiles, glucose control, and quality of life, particularly in CAH patients.
Conclusions:
- Novel glucocorticoid formulations offer significant benefits for AI patients, improving hormonal balance and quality of life.
- These advanced therapies show promise for managing AI, especially in cases with metabolic complications or poor quality of life.
- Further large-scale outcome-based studies are needed to establish the role of these novel strategies in replacing conventional treatments.
Related Concept Videos
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Hormones of the Adrenal Glands
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Anatomy of the Adrenal Glands
These glands possess a distinctive yellow tinge due to the stored cholesterol and fatty acids required for hormone synthesis. They are encased in a fibrous capsule and cushioned by fat.
The adrenal gland comprises two distinct...
Nephrotic Syndrome III : Nursing Management

